We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
Department of Pharmaceutics, Siddhi’s Institute of Pharmacy, Nandgaon Murbad Thane-421401 (Affiliated to Dr Babasaheb Ambedkar Technological University Lonere, Raigad)
Throughout the medication research and manufacturing process, pharmaceutical analysis is essential to guaranteeing the efficacy, safety, and quality of pharmaceutical goods. The principles of drug development and the significance of analytical methods in locating, describing, and measuring active pharmaceutical ingredients (APIs) and excipients are the first topics covered in this thorough review of pharmaceutical analysis. It emphasizes the functions of Quality Control (QC) and Quality Assurance (QA) in preserving product uniformity and adherence to Good Manufacturing Practices (GMP). Major regulatory guidelines published by organizations like the Indian Pharmacopoeia, ICH, WHO, and USFDA are also covered in the research, with a focus on how they help standardize pharmaceutical quality globally. Additionally included are fundamental laboratory procedures, Good Laboratory Practices (GLP), reagent preparation, glassware and analytical instrument calibration, and important instrumental methods including potentiometry, pH determination, and UV-visible spectrophotometry. All things considered, this investigation emphasizes how important analytical techniques and regulatory compliance are to obtaining dependable pharmaceutical quality and patient safety.
Historically, pharmaceutical research has been essential to the advancement of medication discovery since it is driven by chemical principles and directed by pharmacology and clinical sciences. Drug discovery has undergone a transformation thanks to the combined contributions of chemistry, pharmacology, microbiology, and biochemistry. Today's medication development is a different process than in the past, when chemists' inventiveness was mostly responsible for creating new drugs, the outcome of chemists and biologists working together successfully [1,2,4]. Finding a drug molecule having therapeutic promise for treating, controlling, preventing, or curing diseases is the first step in the drug development process. This involves producing and describing these compounds, which are frequently known as active pharmaceutical ingredients (APIs). Additionally, in order to discover possible medication candidates for further research, it is necessary to analyze these compounds in order to produce preliminary data on safety and therapeutic effectiveness [4]. Understanding the fundamental causes of the targeted disease becomes the main emphasis during the early phases of medication discovery. This entails learning more about the genetic changes that cause the illness, examining how proteins interact inside impacted cells, and identifying the modifications brought about by these impacted cells. Equipped with this understanding, researchers create substances that engage with the impacted cells, eventually developing into the finished medication or active pharmaceutical component. This complex and diverse procedure emphasizes how important it is for different scientific domains to work together in order to develop novel medications [5]. The pharmaceutical industry is one of the most regulated in the world due to the requirement to provide safe and effective drugs. The Food and Drug Administration (FDA) requires raw materials to be tested for identity, purity, and quality prior to manufacturing pharmaceutical products. This test ensures that the finished product is suitable for its intended use and is an essential step in the production of pharmaceuticals. Excipients, Active Pharmaceutical Ingredients (APIs), British Pharmacopoeia (BP), Japanese Pharmacopoeia (JP), European Pharmacopoeia (EP), Food Chemical Codex (FCC), and United States Pharmacopoeia (USP)/National Formulary (NF) are just a few of the additive-based final products that we can test. Quality is the result of meticulous effort; it is not a coincidence [6,7].
1.1 Introduction of analytical techniques:
The composition, structure, characteristics, and amount of substances in different samples can be ascertained using a wide range of scientific methods and instruments known as analytical techniques. These methods are used in many different scientific fields, including environmental science, physics, biology, chemistry, and materials science. Analytical methods are crucial for problem-solving, quality assurance, and research [8,9,10].
Figure 1: Analytical Methods Flowchart
1.2 Introduction about QA & QC in pharmaceutical industry:
Quality Control:
Pharmaceutical items are carefully inspected and tested at different stages of manufacture as part of quality control (QC) in order to find and address any flaws or discrepancies. Patient safety is protected by ensuring that every product satisfies the required quality standards prior to going on sale. For medications to be safe, effective, and consistent, QA and QC are essential [17].
Quality Assurance:
QA is concerned with creating and preserving a strong system of procedures, records, and guidelines in order to stop quality problems before they start. It includes not just the caliber of the final product but also the caliber of the complete pharmaceutical production and distribution process [18].
Responsibility of QC:
1. Manage daily quality control
2. Test raw materials, packaging and labels
3. Conduct in-process, finished product and environmental testing
4. Ensure compliance with GMP and select qualified vendors [17,18,19]
Responsibility of QA:
1. Develop a system of quality
2. Checking if the quality system is being followed
3. Specify methods and information
4. Implement production controls
5. Carrying out tests or experiments in the lab
6. Examine each thing and decide whether to accept or reject it.
7. Making certain non-compliance inquiries
8. To provide management with updates [17,18,19]
Table 1: Difference between QA and QC
|
Attribute |
QA |
QC |
|
Goal |
Reducing errors. |
Defect finding. |
|
Focus |
Involving quality into the product from the initial stage of its design. |
Checking the product's quality after it has been manufactured. |
|
Work flow |
Create a system for quality control and ongoing process monitoring. |
Determine the cause of the quality issues. |
|
Type of tool |
Managerial. |
Corrective. |
1.3 Introduction about regulatory guidelines:
Guidelines issued by regulatory agencies in a certain region or nation are known as regulatory guidelines. The quality of the process and product evaluation is enhanced by this guideline.
The main authorities which provide the guideline are-
1. Indian Pharmacopoeia
2. ICH
3. WHO
4. USFDA
1.Indian Pharmacopoeia:
The Indian Pharmacopoeia is an official book that includes the pharmacopoeia's criteria for pharmaceuticals and other related chemicals under the pharmaceuticals and Cosmetics Act of 1940. Pharmaceutical producers are required to adhere to these criteria while preparing medications and other related chemicals. The pharmacopoeias of different nations, including the British, Europe, US, USSR, Japan, National Formulary (USA), and Merck Index, were reviewed in order to prepare the Pharmacopoeia of India. Pharmacopoeias are used by nations to control drug quality. IP, BP, USP, and other pharmacopoeias [14].
2. ICH:
The organisation's full name is "International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use". This group was formed to discuss the scientific and technological issues of drug registration with representatives from regulatory bodies and the pharmaceutical industry. As the pharmaceutical industry grew more global, drug makers had to spend a lot of time and money replicating test methods if they wanted to sell their products abroad, since different countries had different technical criteria. It became more and more important to make safe and effective drugs available to patients all over the world without the delays caused by differences in national regulatory bodies' regulations. The apparent need to rationalise and standardise drug legislation led to the establishment of ICH in 1990[13,15,16,17].
ICH guidelines (QSEM)-
Q: Quality guidelines
S: Safety guidelines
E: Efficacy guidelines
M: Multidisciplinary guidelines
a. Quality guidelines: These recommendations deal with the quality of drug products, focusing on stability studies, impurity testing, and a flexible quality strategy founded on GMP risk management.
b. Safety guidelines: With ICH offering non-clinical techniques (such QT interval monitoring) to avoid drug withdrawals, they aid in the identification of dangers such as genotoxicity, carcinogenicity, and reprotoxicity.
c. Efficacy guidelines: These recommendations include the design, conduct, safety, and reporting of clinical trials, particularly those including medications based on genetics and biotechnology for targeted delivery.
d. Multidisciplinary guidelines: MedDRA, CTD, and ESTRI standards are among the various pharmaceutical subjects covered in this domain.
Table 2 ICH guidelines
|
Guidelins |
Area covers |
|
Q1 A |
Stability testing of novel pharmaceutical ingredients and goods. |
|
Q1 B |
Testing for photostability of novel pharmaceutical ingredients and goods. |
|
Q1 C |
Evaluating novel dosage formulations for stability. |
|
Q1 D |
Designing brackets and matrices for stability assessment of novel pharmaceutical ingredients and goods |
|
Q1 E |
Evaluation of stability data. |
|
Q1 F |
Applications for registration in climate areas III and IV require a stability data package. |
|
Q2 |
Validation of analytical procedures. |
|
Q3 A |
Impurities in new drug substances. |
|
Q3 B |
Impurities in new drug products. |
|
Q3 C |
Guidelines for residual solvents. |
|
Q3 D |
Guidelines for elemental impurities. |
|
Q4 A |
Pharmacopoeial harmonisation. |
|
Q4 B |
Pharmacopoeial texts are evaluated and suggested for usage in ICH regions. |
|
Q5 A |
Analysis of biotechnology products derived from human or animal cell lines for virus safety. |
|
Q5 B |
Analysis of the expression construct in cells that generate r-DNA-derived protein products. |
|
Q5 C |
Biotechnological and biological products are tested for stability. |
|
Q5 D |
Cell substrates utilised to produce biological and biotechnological products are derived and characterised. |
|
Q5 E |
Comparability of biological and biotechnological products based on modifications to their production methods. |
|
Q6 A |
Test procedures and approval criteria for novel drug substances and new drug products apply to chemical compounds. |
|
Q6 B |
Acceptance standards and testing protocols for biological and biotechnological goods. |
|
Q7 |
Good manufacturing practices for Active pharmaceutical ingredients. |
|
Q8 |
Pharmaceutical development. |
|
Q9 |
Quality risk management. |
|
Q10 |
Pharmaceutical quality system. |
|
Q11 |
Development and manufacture of drug substances (chemical and biological entities). |
3. WHO:
On April 7, 1948, the WHO was founded. The World Health Assembly's (WHA) ruling body met for the first time on July 24 of that year. WHO merged the resources, personnel, and responsibilities of the League of Nations Health Organization and the Office for International Hygiene, including the International Classification of Diseases (ICD). Among the public health accomplishments that the WHO has led include the development of the Ebola vaccine, the almost complete eradication of polio, and the eradication of smallpox [18].
4. USFDA:
Industry-specific sterile and non-sterile pharmaceutical recommendations are provided by the US Food and Drug Administration (USFDA). Industry guidelines are often updated by the FDA. All FDA-approved businesses worldwide are required to abide by these regulations [19]. “GLP" stands for "Good Laboratory Practices," which precisely refers to the quality arrangement of organized control for research facilities and organizations to guarantee the stability, dependability, reproducibility, consistency, quality, and synthetic substances containing pharmaceuticals non-clinical security tests, from physicochemical properties through intense to continuous toxicological quality tests [19].
2. Basic Analytical Techniques:
2.1 Basic laboratory skills:
GLP is applicable to non-clinical research carried out to evaluate the safety or effectiveness of medicines and other items under development for humans, animals, and the environment. Standards for laboratory safety, such as the proper gloves, eyewear, and attire to handle lab items safely, are not the same as GLP, a data and operational quality system. In the course of non-clinical and laboratory testing, the GLP principles seek to guarantee and advance the safety, uniformity, high quality, and dependability of chemicals. GLP covers more than just chemicals; it also covers food additives, medical equipment, food packaging, colour, additives, and animal feed [26,27].
GLP principles include:
Objective of GLP:
The process of calibration confirms that an instrument's readings are accurate in relation to predetermined standards.
Hold the buret vertically on a stand. If necessary, use a thermometer to measure the temperature in a different glass tube. To find out the delivery time, fill the buret with distilled water until it reaches the zero mark, then drain it completely and note it. Set the meniscus precisely at zero, record the water temperature, and refill the buret just above zero. Gather water to the appropriate graduation point in a gently stoppered flask that has been previously weighed, then cork and weigh it once more. Refill the thermometer tube after each interval [28].
Using a suction, fill the pipet with pure water until the index mark is reached. Use filter paper to remove any extraneous droplets, then use fine control to accurately adjust to the index mark while maintaining contact between the tip and the beaker wall. Note the temperature of the water. Transfer the water vertically into a flask that has been previously weighed, holding the tip against the flask's neck until the outflow stops. The delivered volume can be found by stopping the flask and weighing it once more [29].
Figure 2: Pipets
Using a stopper, weigh the dry, clean flask. Then, use a funnel to fill it just below the graduation line. After two minutes, let it stand. Finally, fill it to the meniscus and weigh it once more. Check the water's temperature in the flask itself, if it's big enough, or from the filling beaker or supply line [30].
2.3 Calibration of analytical instruments:
A] Calibration of analytical balance:
Figure 3: Calibration of analytical balance
B] Calibration of sonicator:
i. The external agency's calibration frequency is once a year.
ii. The internal agency's quarterly calibration frequency
iii. Adjust two parameters to calibrate the apparatus. Calibration of time.
iv. Make sure the stopwatch is certified and calibrated prior to calibration.
v. Press the desired key to set the time to five minutes, then turn on the apparatus and stopwatch. After the competition, note the outcome. This is a duplicate excise.
vi. Repeat the process after setting 10 and 25 minutes again.
vii. For corrective and preventive action, report any disparity found during equipment calibration to the in-charge or his designee.
viii. The Maintenance Department service engineer is notified of the defect by the ADL In-Charge or his designee in order to fix it. Put 'Under Maintenance' on the equipment. After maintenance, calibration should be necessary [29].
Figure 4: Sonicator
C] Calibration of UV-visible spectrophotometer:
Harshada Ingle*, Priti Kedar, Rutik Jadhav, Mohit Pawar, Mohit Jadhav, Pharmaceutical Analysis: Analytical Techniques, Quality Systems, and Regulatory Perspectives for Ensuring Drug Quality and Safety, Int. J. Med. Pharm. Sci., 2026, 2 (1), 1-15. https://doi.org/10.5281/zenodo.18126443
10.5281/zenodo.18126443